| NCT ID | NCT05817734 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Weizmann Institute of Science |
| Condition | Adult Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 30,000 participants |
| Start Date | 2018-10-01 |
| Primary Completion | 2045-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30,000 participants in total. It began in 2018-10-01 with a primary completion date of 2045-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a prospective study aimed at recruiting 30,000 individuals, aged 40-70 years old, and following them longitudinally for 25 years with repeated measurements. The basic follow-up frame will include a visit to the Clinical Test Center (CTC) every two years and a phone interview every other year (on uneven years). Sample collection and biobanking will be performed every two years and online questionnaires will be filled out on an annual basis. The primary goals are to study the variation observed across different individuals in disease susceptibility, clinical phenotypes, and therapeutic responses. The study aims at studying the complex interplay and relative contribution of different omics, physiological characteristics and lifestyle on disease pathogenesis and progression and to evaluate how these effects are mediated.
Eligibility Criteria
Inclusion Criteria: * Ages 18+, males and females. Exclusion Criteria: * Pregnancy. * Mentally disabled or in general legally non-competent. * Prisoner or soldier. Soldiers: mandatory service only * Active cancer * Fertility Treatments (current) * Hepatitis ( B, C), chronic or acute * HIV * Liver cirrhosis * Dialysis * Unstable medical conditions
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05817734 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Adult Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05817734 currently recruiting?
Yes, NCT05817734 is actively recruiting participants. Contact the research team at Eran.Segal@weizmann.ac.il for enrollment information.
Where is the NCT05817734 trial being conducted?
This trial is being conducted at Rehovot, Israel.
Who is sponsoring the NCT05817734 clinical trial?
NCT05817734 is sponsored by Weizmann Institute of Science. The trial plans to enroll 30,000 participants.